First Patient Enrolled in Merit Medical’s WRAPSODY North America Registry

The WRAP North America registry, a prospective, multicenter study, has been established to gather real-world safety and effectiveness data on the WRAPSODY Cell-Impermeable Endoprosthesis (CIE). The first patient enrolled in this registry was registered at Bluff City Vascular, an interventional nephrology and vascular access center located in Memphis, TN. On August 18, 2025, Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global healthcare technology company, announced the successful enrollment of this inaugural patient in the WRAP North America registry.